Publicaciones científicas

Allograft morphology and function in heart transplant recipients surviving more than 15 years by magnetic resonance imaging and dual-source computed tomography

Mastrobuoni S, Dell'aquila AM, Arraiza M, Bastarrika G, Azcarate PM, Pueyo J, Rabago G, Herreros J.
Department of Cardiovascular Surgery, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain

Revista: European Journal of Cardio-Thoracic Surgery

Fecha: 28-mar-2011

Cardiología Cirugía Cardíaca Radiología

Objective
Cardiac allograft vasculopathy and late graft failure are the main limiting factors of long-term success of heart transplantation, and little is known about graft function in the long-term survivors.

The aim of this study was to assess the ventricular function and the allograft vasculopathy in long-term survivors (>15 years) with the cardiac magnetic resonance imaging (MRI) and dual-source computed tomography (DSCT) coronary angiogram.

Methods
In our database, 34 cardiac recipients have more than 15 years of follow-up and were evaluated for this study; 22 (65%) of them were enrolled. Mean age at transplant was 46±13.5 years, mean donor age was 28.5±10.1 years, and mean graft ischemic time was 189±58min. Mean follow-up was 18.5±2.4 years (range 15-22). All patients underwent cardiac MRI and DSCT.

Results
Mean left ventricular (LV) volumes indexed to the body surface area (BSA) were within normal range: the end-diastolic volume/BSA was 61±16mlm(-2), end-systolic volume/BSA was 22±15mlm(-2), stroke volume/BSA was 38±6mlm(-2), LV mass/BSA: 72±18gm(-2), and mean ejection fraction (EF) was 0.59±0.08. Two patients (9%) showed a global cardiac hypokinesia and two other patients (9%) showed akinesia of one segment. At DSCT, 41% of patients had a strictly normal coronary angiogram, 41% had wall thickening and 18% presented a least one >60% stenosis.

Conclusions
Cardiac MRI and DSCT coronary angiogram revealed a normal graft function and morphology after more than 15 years of transplantation. However, a certain number of patients have significant cardiac allograft vasculopathy and another consistent group has initial disease. These patients deserve further follow-up and tailoring of the immunosuppressive regimen.

CITA DEL ARTÍCULO  Eur J Cardiothorac Surg. 2011 Mar 28

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra